Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria

Pediatrics

Volumn 118, Issue 6, 2006, Pages

  Rand, Elizabeth B ^a,d   Bunin, Nancy ^a   Cochran, William ^b   Ruchelli, Eduardo ^a   Olthoff, Kim M ^a   Bloomer, Joseph R ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALABAMA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Bone marrow transplantation; Liver transplantation; Porphyria

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; ERYTHROPOIETIC PROTOPORPHYRIA; HUMAN; LIVER FAILURE; LIVER GRAFT; LIVER INJURY; LIVER TRANSPLANTATION; PHENOTYPE; PHOTOSENSITIVITY; PRIORITY JOURNAL; SPLENECTOMY; ADOLESCENT; CASE REPORT; MALE; METHODOLOGY;

ADOLESCENT; BONE MARROW TRANSPLANTATION; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PROTOPORPHYRIA, ERYTHROPOIETIC;

EID: 33947170983     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-0833     Document Type: Article

References (16)

1. Bloomer J, Wang Y, Singhal A, Risheg H. Molecular studies of liver disease in erythropoietic protoporphyria. J Clin Gastroenterol. 2005;39(4 suppl 2):S167-S175
2. Gross U, Frank M, Doss MO. Hepatic complications of erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed. 1998;14:52-57
3. Avner DL, Lee RG, Berenson MM. Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver. J Clin Invest. 1981;67:385-394
4. Avner DL, Larsen R, Berenson MM. Inhibition of liver surface membrane, Na,K-adenosine triphosphatase, Mg-adenosine triphosphatase and 5′-nucleosidase activities by protoporphyrin: observations in vitro and in the perfused rat liver. Gastroenterology. 1983;85:700-706
5. Meerman L, Koopen NR, Bloks V, et al. Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria. Gastroenterology. 1999;117:696-705
6. Mathews-Roth MM, Pathak MA, Fitzpatrick TB, Harber LH, Kass EH. Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. Arch Dermatol. 1977;113:1229-1232
7. Potter C, Tolaymat N, Bobo R, Sharp H, Rank J, Bloomer J. Hematin therapy in children with protoporphyric liver disease. J Pediatr Gastroenterol Nutr. 1996;23:402-407
8. Reichheld JH, Katz E, Banner BF, Szymanski IO, Saltzman JR, Bonkovsky HL. The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for orthotopic liver transplantation for erythropoietic protoporphyria. Transplantation. 1999;67:922-928
9. Dellon ES, Szczepiorkowski ZM, Dzik WH, et al. Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation. 2002;73:911-915
10. Torres ID, Demetris AJ, Randhawa PS. Recurrent hepatic allograft injury in erythropoietic protoporphyria. Transplantation. 1996;61:1412-1413
11. Rollwagen FM. Hepatic allograft injury in erythropoietic protoporphyria. Transplantation. 1997;63:485-486
12. McGuire BM, Bonkovsky HL, Carithers RL, et al. Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transplantation. 2005;11:1590-1596
13. Gouya L, Puy H, Robreau AM, et al. The penetrance of dominant erythropoietic protoporphyria is modulated by the expression of wildtype FECH. Nat Genet. 2002;30:27-28
14. Schneider-Yin X, Gouya L, Meier-Weinand A, Deybach JC, Minder EI. New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care. Eur J Pediatr. 2000;159:719-725
15. Poh-Fitzpatrick MB, Wang X, Anderson KE, Bloomer JR, Bolwell B, Lichtin AE. Erythropoietic protoporphyria: altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutations. J Am Acad Dermatol. 2002;46:861-866
16. Pawliuk R, Bachelot T, Wise RJ, Matthews-Roth MM, Leboulch P. Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy. Nat Med. 1999;5:768-773